Although significant improvements have been made in the outcomes of children with cancer,
the pace of improvement has slowed in recent years as the limits of therapy intensification …

After decades of research, immunotherapies for cancer are demonstrating increasing
success. These agents can amplify existent antitumour immunity or induce durable …

Overall survival from childhood malignancies has dramatically improved, with survival rates
now reaching over 70%. Nevertheless, some types of childhood cancer remain a difficult …

The outcome for children with cancer has improved significantly over the past 60 years, with
greater than 80% of patients today becoming 5‐year survivors. Despite this progress, cancer …

Four out of five children diagnosed with cancer can be cured with contemporary cancer
therapy. This represents a dramatic improvement since 50 years ago when the cure rate of …

Remarkable advances in the treatment of childhood and adolescent cancer have resulted in
substantial improvements in 5-and 10-year survival for the vast majority of cancer …

The Children's Oncology Group (COG) recently celebrated the milestone of 50 years of
pediatric clinical trials and collaborative research in oncology. Our group had its origins in …

Now thoroughly updated to include new advances in the field, and with regular content
updates to the eBook, Principles and Practice of Pediatric Oncology, 7th Edition remains the …

Improvements in protocol-driven clinical trials and supportive care for children and
adolescents with cancer have reduced mortality rates by more than 50% over the past three …

Cancer immunotherapies, widely heralded as transformational for many adult cancer
patients, are becoming viable options for selected subsets of pediatric cancer patients. Many …